These results suggest that exercise training with intermittent hyperbaric exposure represents a beneficial strategy for increasing endurance performance by facilitating oxidative and glycolytic capacities and the expression of proteins involved in mitochondrial biogenesis in the hindlimb muscles.
Triple-negative breast cancer (TNBC) is more aggressive and metastatic than other breast cancer types. Cytotoxic chemotherapy is presently the predominant systemic therapy for TNBC patients. This case report highlights the influence of metabolically supported chemotherapy (MSCT), ketogenic diet (KD), hyperthermia (HT), and hyperbaric oxygen therapy (HBOT) in an overweight 29-year-old woman with stage IV (T4N3M1) triple-negative invasive ductal carcinoma of the breast.
A 9-week treatment of low-pressure hyperbaric oxygen therapy (40 sessions) in a patient with Alzheimer's Dementia caused a significant increase in global metabolism on 18FDG PET imaging with concomitant symptomatic improvement. Mild symptomatic regressionwas treated with intermittent HBOT, normobaric oxygen, and medications to stabilize symptoms, suggesting the possibility of long-term HBOT treatment of AD with pharmacotherapy.
The benefits of treating toxic exposure patients with Hyperbaric Therapy appear to be very positive. Initial results indicate that Hyperbaric Therapy has a demonstrable and positive effect on some symptoms such as short term memory loss and balance.
Patients with visual loss secondary to Age Related Macular Degeneration (AMD) underwent hyperbaric oxygen therapy and achieved improvements in their visual acuity and/or visual eld in cases considered untreatable by presently accepted methods.